Research and Clinical Trials
We are proud to be leaders in rheumatologic research. Our division is involved in numerous clinical trials and research studies aimed at discovering new therapies and improving existing treatments. Participation in clinical trials offers our patients access to cutting-edge treatments and contributes to the advancement of medical knowledge.
Leading the Way in Innovation
Research programs span the spectrum from studies in the fundamental biology of immunologic and inflammatory diseases to clinical trials that test novel therapies in patients. Our internationally-recognized research programs are funded by a wide range of sources including the National Institutes of Health, the Arthritis Foundation, philanthropic efforts, and industry.
Faculty in the Division of Rheumatology are involved in the following research areas:
- Antigen Presentation
- B-cell Function and Autoantibodies
- Biomarkers Cell Adhesion Clinical Trials
- Crystal-Mediated Disease
- Innate Immunity
- Pathogenesis of Rheumatoid Arthritis
- Pathogenesis of SLE
- Signal Transduction
- Pathogenesis of Psoriatic Arthritis via synovial tissue analysis
- Use of musculoskeletal ultrasound in identification of joint and tendon pathology in rheumatic conditions